Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 85/100

Failure Rate

25.0%

2 terminated/withdrawn out of 8 trials

Success Rate

60.0%

-26.5% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A

6(85.7%)

Phase 4

1(14.3%)

7Total

N/A(6)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT06549218Not ApplicableRecruiting

Genetic Newborn Screening for Rare Diseases Within the Screen4Care Project

Role: collaborator

NCT06872151Phase 4Completed

Evaluation of the Effectiveness of a Topical Medical Device in Wound Healing and Symptom Relief in the Postoperative Period of Open Excisional Hemorrhoidectomy (The Emor Study)

Role: collaborator

NCT06240195Recruiting

Biomarkers of Efficacy and Tolerability of Sacituzumab-Govitecan in the Treatment of Patients With Triple-negative Breast Cancer in the Metastatic Phase: Prospective Multicenter Real-world Study

Role: collaborator

NCT04111250Not ApplicableCompleted

Crestal vs Lateral Sinus Lift Augmentation

Role: lead

NCT01104363Not ApplicableWithdrawn

Splint Versus Non-splint Implant Impressions

Role: lead

NCT01107600Not ApplicableWithdrawn

Study on Immediate Loading of Immediately Placed Single Implants.

Role: lead

NCT02772835Not ApplicableCompleted

nHFOV vs nCPAP: Effects on Gas Exchange for the Treatment of Neonates Recovering From RDS